Similar Articles
2781 Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells
2782 Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease
2783 Constant serum levels of secreted asialoglycoprotein receptor sH2a and decrease with cirrhosis
2784 Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation
2785 Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated?
2786 Proteome-based biomarkers in pancreatic cancer
2787 Hepatitis B virus infection and the risk of hepatocellular carcinoma
2788 Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma
2789 Liver transplantation for hepatocellular carcinoma on cirrhosis: Strategies to avoid tumor recurrence
2790 Molecular predictors of gemcitabine response in pancreatic cancer
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA